XML 22 R13.htm IDEA: XBRL DOCUMENT v3.23.3
Balance Sheet Components
9 Months Ended
Sep. 30, 2023
Balance Sheet Components  
Balance Sheet Components

7. Balance Sheet Components (in thousands)

September 30, 

December 31, 

    

2023

    

2022

Prepaid and Other Current Assets

Interest receivable

$

39

$

45

Prepaid research and development manufacturing expenses

149

192

Prepaid facility expenses

196

182

Prepaid insurance

317

252

Other

 

214

 

102

$

915

$

773

Property and Equipment

Laboratory equipment

$

2,678

$

2,673

Computer equipment and purchased software

 

171

 

142

Leasehold improvements

 

2,084

 

2,084

 

4,933

 

4,899

Less: accumulated depreciation and amortization

 

(4,669)

 

(4,546)

$

264

$

353

Accrued and Other Liabilities

Accrued clinical trial expense

$

2,603

$

2,934

Accrued manufacturing expense

 

592

 

3,254

Personnel related

 

751

 

1,113

Accrued legal and accounting

351

89

Other

 

262

 

158

$

4,559

$

7,548

During the three months ended September 30, 2023 and 2022, the Company recorded approximately $30,000 and $94,000 in depreciation expense, respectively, and during the nine months ended September 30, 2023 and 2022, the Company recorded approximately $123,000 and $273,000 in depreciation expense, respectively.